Donor Lymphocyte Infusion ในผู้ป่วยลิวคีเมียที่มีโรคกลับ หลังการปลูกถ่ายไขกระดูก
Keywords:
-Abstract
-
Downloads
References
Giralt S, Champlin R. Leukemia relapse after allogeneic bone marrow transplantation : a review. Blood 1994;84:3603.
Slavin S, Naparsteh E, Nagler A, Ackertein A, Kapelushnik J. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor lymphocytes. Experimental Hematology 1995,23:1553.
Bortin M, Horowitz M, Gale R, et al. Changing trands in allogeneic bone marrow transplantation for leukemia. JAMA 1992;268:607.
Champlin R, Mc Glave P. Allogeneic bone marrow transplantation for chronic myelogenous leukemia. In: Forman S, Blume K, Thomas E, eds. Bone Marrow Transplantation. Boston:Blackwell Scientific, 1994:595.
Long G, Blume K. Allogeneic bone marrow transplantation for acute myeloid leukemia. In : Forman S, Blume K. Thomas E, eds. Bone Marrow Transplantation. Boston:Blackwell Scientitic, 1994;607.
Chao N, Forman S. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia. In : Forman S, Blume K, Thomas E, eds. Bone Marrow Transplantation. Boston:Blackell Scientic, 1994,618.
Goldman J, Gale R. Horowitz M, et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase : Increased risk of relapse associated with T cell depletion. Ann Intern Med 1988;108:806.
Horowitz M, Gale R, Sondel M, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990;75:555.
Marmont A, Horowitz M, Gale R, et al. T cell depletion of HLA-identical transplantation in leukemia. Blood 1991;78:2120.
Sullivan K, Weiden P, Storh R, et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989;73:1720.
Zender A, Keating M, Dicke K, et al. A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission. J Clin Oncol 1988;6:1548.
Przepiorka D, Thomas E. Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia. Bone Marrow Transplant 1989;3:113.
Goldstone A, Burnette A, Stevens R, et al. Evaluation of BMT (allo or auto) in addition to intensive chememotherapy for AMI. in first remission : Preliminary results of AML-10 for 1572 patients. Proc Am Soc Clin Oncol 1994(abstr);13:305a.
Weiner R, Gale R, Horowitz M, Bortin M. Impact of cytogenetic abnormalities on outcome of bone marrow transplantation for acute myelogenous leukemia. Blood 1991;78:244a.
Frassoni F, Barrette J, Granena A, et al. Relapse after allogeneic bone marrow transplantation for acute leukemia. A servey of the EBMTR of 117 cases. Br J Hematol 1988;70:317.
Mortimer J, Binder M, Schulman S, et al. Relapse of acute leukemia after marrow transplantation. Natural history and results of subsequent therapy. J Clin Oncol 1989;750.
Arcese W, Goldman J, Areangelo E, et al. Outcome of patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Blood 1993;82:3211.
Weiden P, Fluornoy N, Thomas E, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 1979;300:1068.
Welden P, Sullivan K, Fluornoy N, Storb R, Thomas E. Antileukemic effect of araftversus-host disease : Contributions to improved survival after aloogeneic bone marrow transplantation. N Eng! J Med 1991,304:1529.
Weisdort N, Nesbit M, Rramsey N, et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission : Prolonged survival associated with acute graftversus-host disease. J Clin Oncol 1987;5:1348.
Fefer A, Sulivan K, Welden P, et al. Graft versus leukemia effectin man : The relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. Prog Clin Biol Res 1987;244:401.
Gale R, Horowitz M, Ash R, et al. Identical twin bone marrow transplants for leukemia. Ann Intern Med 1994;120:646.
Martin P, Hansen J, Buckner C. Effect of in vitro depletion of T cells in HILA-identical allogeneic marrow grafts. Blood 1985;66:664.
Apperky J, Jones L, Hale G, et al. Bone marrow transplantation for patients with chronic myeloid leukemia : T cell depletion with campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukemia relapse. Bone marrow transplant 1986;1:53.
Mitsuyasu R, Champlin R, Gale R, et al. Depletion of T-lymphocytes from donor bone marrow for the prevention of graft-versus-host disease following bone marrow transplantation. Ann Intern Med 1986;105:20.
Maraninchi D, Ghuckman E, Blaise, et al. Impact of of T cell depletion on outcome of alloge transplantation for standard rosk leukemias. Lancet 1987:2:175.
Barnes D, Loutit J. Treatment of murine leukemia with X-rays and homologous bone marrow marrow : II. Br J Haematol 1957;3:241.
Math G. Amiel J, Schwarzenbug L, Catton A, Schneider M. Adoptive immunotherapy for acute leukemia : Experimental and clinical results. Cancer Res 1965;25:1525.
Odom L. Githers I, Morse H, et al. Remission of relapsed leukemia during graft-versus-host reaction : A graft-versus-leukemia reaction in man? Lancet 1978:2:257.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
